General Announcement::Intimation of Board Meeting

Issuer & Securities

Issuer/ Manager: GLENMARK PHARMACEUTICALS LIMITED
Securities: GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security: No

Announcement Title: General Announcement
Date &Time of Broadcast: 14-May-2019 21:27:09
Status: New
Announcement Sub Title: Intimation of Board Meeting
Announcement Reference: SG190514OTHRL42M
Submitted By (Co./ Ind. Name): Glenmark Pharmaceuticals Limited
Designation: Company Secretary & Compliance Officer
Description (Please provide a detailed description of the event in the box below): We have to inform you that, pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, a meeting of the Board of Directors will be held on Wednesday, May 29, 2019, inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2019 and to consider and recommend dividend, if any, on Equity Shares for the year ended March 31, 2019.

Further, as per the "Code of Conduct for Prevention of Insider Trading" and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Company has intimated its Directors and other designated persons regarding the closure of trading window from April 1, 2019 to May 31, 2019 (both days inclusive) for the purpose of approval of Standalone and Consolidated Audited Financial Results for the year ended March 31, 2019.

Total size =340K